When compared to LUAD-AF and LUAD-RF variants, our radiogenomics framework derived ACE2-RGF demonstrated consistent performance for classifying LUAD (Table 2) and COVID-19 (Table 3) patients from normal subjects. The gene discussed is ACE2; the disease is COVID-19.